1. Oncogenic signaling of MEK5-ERK5
   Van T. Hoang et al, 2017, Cancer Letters CrossRef
2. Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2)
   Syed Ahmad et al, 2018, Biochemical and Biophysical Research Communications CrossRef
3. Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity
   Syed Ahmad et al, 2015, Biochemical and Biophysical Research Communications CrossRef
4. MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function
   Jinqiu Lu et al, 2018, Oncogene CrossRef
5. KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
   PANAGIOTIS PALIOGIANNIS et al, 2014, Oncology Letters CrossRef
6. MAP3K2 augments Th1 cell differentiation via IL-18 to promote T cell-mediated colitis
   Ningbo Wu et al, 2021, Science China Life Sciences CrossRef
7. Clinical Significance and Regulation of ERK5 Expression and Function in Cancer
   Matilde Monti et al, 2022, Cancers CrossRef
8. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers
   Hong-Beom Park et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef